These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17591353)

  • 1. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
    Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
    In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
    Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
    In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic approach for cancer using four cardiovascular hormones.
    Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
    Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilator.
    Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
    In Vivo; 2010; 24(2):125-9. PubMed ID: 20363982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.
    Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
    Eur J Clin Invest; 2010 Mar; 40(3):242-9. PubMed ID: 20415699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.
    Eichelbaum EJ; Sun Y; Alli AA; Gower WR; Vesely DL
    Eur J Clin Invest; 2008 Aug; 38(8):562-70. PubMed ID: 18717826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
    Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
    Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical localization of atrial natriuretic peptide, vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide in human pancreatic adenocarcinomas.
    Saba SR; Garces AH; Clark LC; Soto J; Gower WR; Vesely DL
    J Histochem Cytochem; 2005 Aug; 53(8):989-95. PubMed ID: 15879575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.
    Skelton WP; Pi G; Lenz A; Sun Y; Vesely DL
    Eur J Clin Invest; 2010 Aug; 40(8):706-12. PubMed ID: 20546014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central role of β-catenin in anticancer effects of cardiac hormones.
    Skelton WP; Skelton M; Vesely DL
    Anticancer Res; 2013 Jun; 33(6):2409-14. PubMed ID: 23749889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.
    Skelton WP; Skelton M; Vesely DL
    Anticancer Res; 2013 Mar; 33(3):785-90. PubMed ID: 23482745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptides: anticancer agents.
    Vesely DL
    J Investig Med; 2005 Nov; 53(7):360-5. PubMed ID: 16297362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
    Vesely DL; Perez-Lamboy GI; Schocken DD
    Metabolism; 2000 Dec; 49(12):1592-7. PubMed ID: 11145122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
    Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
    Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five cardiac hormones decrease the number of human small-cell lung cancer cells.
    Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Alli AA; Solivan SM; Gower WR; Vesely DL
    Eur J Clin Invest; 2005 Jun; 35(6):388-98. PubMed ID: 15948900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four cardiac hormones cause death of human cancer cells but not of healthy cells.
    Skelton WP; Pi GE; Vesely DL
    Anticancer Res; 2011 Feb; 31(2):395-402. PubMed ID: 21378317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2007; 27(3B):1387-92. PubMed ID: 17595752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Skelton WP; Lenz A; Wang H; Vesely DL
    Anticancer Res; 2009 Apr; 29(4):971-5. PubMed ID: 19414334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.
    Vesely DL; Perez-Lamboy GI; Schocken DD
    J Card Fail; 2001 Mar; 7(1):55-63. PubMed ID: 11264551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.